| 16.12.2024 07:00 | CIZ | Update on Strategic Partnership in North America | RNS |
| 03.10.2024 13:12 | CIZ | Update on Licensing and Partnership Agreement | RNS |
| 30.09.2024 18:37 | CIZ, DGI, OHT | EARNINGS: Alliance Pharma swings to profit; DG Innovate loss widens | Alliance |
| 30.09.2024 07:00 | CIZ | Interim Results | RNS |
| 16.09.2024 07:00 | CIZ | Holding(s) in Company | RNS |
| 09.09.2024 22:03 | PANR, UKOG, CIZ | TRADING UPDATES: Light Science Technologies wins two new contracts | Alliance |
| 09.09.2024 07:00 | CIZ | Collaboration with Moffitt Cancer Center | RNS |
| 25.07.2024 07:00 | CIZ | Update on Strategic Partnership in North America | RNS |
| 18.07.2024 07:00 | CIZ | Manufacturing Agreement with BBI Solutions | RNS |
| 09.07.2024 07:00 | CIZ | Issue of Share Options in Lieu of Consultancy Fees | RNS |
| 24.06.2024 12:42 | CIZ | Result of AGM | RNS |
| 17.06.2024 15:53 | CHSS, THG, SAV | UK shareholder meetings calendar - next 7 days | Alliance |
| 17.06.2024 13:33 | CIZ | Cizzle says CIZ1B biomarker test picked for "major" US cancer study | Alliance |
| 17.06.2024 07:00 | CIZ | Update on North American Strategic Licensing MoU | RNS |
| 03.06.2024 07:00 | CIZ | Notice of Annual General Meeting | RNS |
| 13.05.2024 07:00 | CIZ | Holding(s) in Company | RNS |
| 30.04.2024 17:00 | CIZ | Total Voting Rights | RNS |
| 30.04.2024 16:30 | CODE, KLSO, S247 | EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down | Alliance |
| 30.04.2024 09:12 | CIZ | Final results for the year ended 31 December 2023 | RNS |
| 23.04.2024 11:20 | CIZ | Holding(s) in Company | RNS |
| 02.04.2024 15:19 | ORCA, CIZ, ANIC | TRADING UPDATES: MaxCyte inks deal with Be Bio; Orcadian firms farmout | Alliance |
| 02.04.2024 07:00 | CIZ | Licensing and Partnership MoU for North America | RNS |
| 26.03.2024 15:39 | POW, WYN, TON | TRADING UPDATES: BATM Advanced ink USD2.3 million orders | Alliance |
| 26.03.2024 07:00 | CIZ | Placing to raise £0.62 million | RNS |
| 28.09.2023 18:29 | ADME, RBD, PXC | EARNINGS: Cizzle Biotechnology loss widens as admin costs mount | Alliance |
| 28.09.2023 07:00 | CIZ | Interim Results | RNS |
| 21.09.2023 11:14 | VELA, CIZ | Vela Technologies and Cizzle Biotechnology rise on Conduit listing | Alliance |
| 21.09.2023 10:49 | CIZ, VELA, HMI | AIM WINNERS & LOSERS: Vela and Cizzle up as Conduit takes NY listing | Alliance |
| 21.09.2023 07:00 | CIZ | Update on Put Option with Conduit | RNS |
| 19.09.2023 17:26 | JTC, TEK, CIZ | TRADING UPDATES: Tekcapital's portfolio company seals joint venture | Alliance |
| 19.09.2023 07:00 | CIZ | Completion of Evaluation Programme with Bio-Techne | RNS |
| 08.09.2023 14:29 | CIZ | Cizzle says meeting to approve sale of AZD1656 interest postponed | Alliance |
| 08.09.2023 07:03 | CIZ | Extension of and update on Put Option with Conduit | RNS |
| 15.08.2023 10:48 | AZN, VELA, CIZ | Murphy Canyon to hold meeting on planned buy of interest in AZD1656 | Alliance |
| 15.08.2023 07:00 | CIZ | Update on Put Option with Conduit | RNS |
| 10.08.2023 14:38 | ATN, POW, CKT | TRADING UPDATES: Aterian granted 10 exploration licences in Morocco | Alliance |
| 10.08.2023 07:00 | CIZ | Expansion of Research Agreement and CIZ1B Update | RNS |
| 30.06.2023 17:00 | CIZ | Total Voting Rights | RNS |
| 28.06.2023 12:01 | CIZ | Result of AGM | RNS |
| 21.06.2023 15:43 | ZED, WSG, W7L | UK shareholder meetings calendar - next 7 days | Alliance |
| 12.06.2023 14:15 | CIZ | Total Voting Rights | RNS |
| 12.06.2023 10:15 | CIZ | Cizzle subscription raises GBP350,000 to fund development pipeline | Alliance |
| 12.06.2023 07:00 | CIZ | Subscription to raise £350,000 | RNS |
| 05.06.2023 12:35 | CIZ | Posting of Annual Report and Notice of AGM | RNS |
| 15.05.2023 21:10 | CGNR, VAST, CIZ | TRADING UPDATES: Online Blockchain keeping ADVFN at "arms length" | Alliance |
| 15.05.2023 13:42 | CIZ | Update on Royalty Sharing Agreement in AZD1656 | RNS |
| 27.04.2023 17:02 | SEED, MSMN, PALM | TRADING UPDATES: Ceiba net asset value down, up for Asia Dragon Trust | Alliance |
| 27.04.2023 07:00 | CIZ | Results for the year ended 31 December 2022 | RNS |
| 24.04.2023 09:34 | CIZ | Cizzle extends partnership with York University for cancer research | Alliance |
| 24.04.2023 07:00 | CIZ | New Research Agreement with the University of York | RNS |
| 30.03.2023 11:05 | CIZ | Second Price Monitoring Extn | RNS |
| 30.03.2023 11:00 | CIZ | Price Monitoring Extension | RNS |
| 17.03.2023 16:35 | CIZ | Price Monitoring Extension | RNS |
| 13.03.2023 09:00 | CIZ | Price Monitoring Extension | RNS |
| 07.03.2023 07:00 | CIZ | Issue of Options in lieu of salary increases | RNS |
| 22.02.2023 07:52 | CIZ | Holding(s) in Company | RNS |
| 06.02.2023 07:02 | CIZ | Holding(s) in Company | RNS |
| 31.01.2023 17:00 | CIZ | Total Voting Rights | RNS |
| 24.01.2023 12:48 | CIZ | Holding(s) in Company | RNS |
| 23.12.2022 18:15 | PRTC, SOHO, KRPZ | TRADING UPDATES: Fiinu teams with TransUnion; GRC wins pact | Alliance |
| 20.12.2022 15:17 | CIZ | Update re. timing of Admission | RNS |
| 19.12.2022 07:00 | CIZ | Put Option re AZD1656 & £115,586 Subscription | RNS |
| 23.11.2022 16:58 | CIZ | IN BRIEF: Cizzle Biotechnology signs lung-cancer study in China | Alliance |
| 23.11.2022 08:04 | CIZ | Clinical Study for Lung Cancer Detection in China | RNS |
| 09.11.2022 20:41 | CIZ, VELA | UPDATE: Cizzle, Vela Technologies notes planned Conduit Pharma merger | Alliance |
| 09.11.2022 07:00 | CIZ | Conduit Pharmaceuticals Proposed Listing | RNS |
| 31.10.2022 17:00 | CIZ | Total Voting Rights | RNS |
| 04.10.2022 08:00 | CIZ | Admission and Total Voting Rights | RNS |
| 30.09.2022 17:00 | CIZ | Total Voting Rights | RNS |
| 29.09.2022 15:49 | CIZ | Issue of Consideration Shares & Option Exercise | RNS |
| 28.09.2022 15:05 | CIZ | Holding(s) in Company | RNS |
| 28.09.2022 14:43 | CIZ | Cizzle Biotechnology reports narrowed loss as passes "key milestones" | Alliance |
| 28.09.2022 07:00 | CIZ | Interim results | RNS |
| 26.09.2022 08:00 | CIZ | Admission and Total Voting Rights | RNS |
| 21.09.2022 11:23 | CIZ | Subscription, Facility & Publication of Prospectus | RNS |
